Investigating a new regulator of blood vessel function in heart failure
ARNT: A novel regulator of cardiac vascular endothelial barrier function in heart failure
This study is looking at how restoring blood flow after a heart attack can sometimes cause more damage to the heart, and it’s exploring a special protein that might help protect the heart during this process, which could lead to better treatments for patients in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10544491 on NIH RePORTER |
What this research studies
This research focuses on understanding how blood flow restoration after a heart attack can lead to additional heart damage, known as ischemia-reperfusion injury. The study examines the role of a specific protein, ARNT, in regulating the permeability of blood vessels in the heart. By using genetically modified mice, researchers aim to uncover the molecular mechanisms that contribute to heart damage and identify potential new treatments to prevent this injury. Patients may benefit from insights gained into how to protect the heart during and after reperfusion.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced a heart attack and are at risk of developing heart failure.
Not a fit: Patients who have not had a heart attack or those with advanced heart failure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing heart damage after a heart attack.
How similar studies have performed: Other research has shown promise in understanding vascular permeability and its role in heart injury, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Wu, Rongxue — University of Chicago
- Study coordinator: Wu, Rongxue
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.